Research and Markets has announced the addition of the "Trypanosomiasis Pipeline Highlights - 2017" drug pipelines to their offering.

This report, Trypanosomiasis Pipeline Highlights - 2017, provides most up-to-date information on key pipeline products in the global Trypanosomiasis market. It covers emerging therapies for Trypanosomiasis in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Trypanosomiasis pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Trypanosomiasis pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides Trypanosomiasis pipeline products by the company.

Short-term Launch Highlights:

Find out which Trypanosomiasis pipeline products will be launched in the US and Ex-US till 2020.

Summary:

  • Trypanosomiasis phase 3 clinical trial pipeline products
  • Trypanosomiasis phase 2 clinical trial pipeline products
  • Trypanosomiasis phase 1 clinical trial pipeline products
  • Trypanosomiasis preclinical research pipeline products
  • Trypanosomiasis discovery stage pipeline products
  • Trypanosomiasis pipeline products short-term launch highlights

Key Topics Covered:

1. Trypanosomiasis Pipeline by Stages

2. Trypanosomiasis Pipeline by Drug Class

3. Trypanosomiasis Pipeline by Company

4. Trypanosomiasis Phase 3 Clinical Trial Insights

5. Trypanosomiasis Phase 2 Clinical Trial Insights

6. Trypanosomiasis Phase 1 Clinical Trial Insights

7. Trypanosomiasis Preclinical Research Insights

8. Trypanosomiasis Discovery Stage Insights

9. Appendix

10. Research Methodology

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/mcxgsx/trypanosomiasis